Michael J. Orwat

1.2k total citations
16 papers, 782 citations indexed

About

Michael J. Orwat is a scholar working on Hematology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Michael J. Orwat has authored 16 papers receiving a total of 782 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Hematology, 5 papers in Organic Chemistry and 5 papers in Pharmacology. Recurrent topics in Michael J. Orwat's work include Blood Coagulation and Thrombosis Mechanisms (6 papers), Inflammatory mediators and NSAID effects (5 papers) and Atrial Fibrillation Management and Outcomes (3 papers). Michael J. Orwat is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (6 papers), Inflammatory mediators and NSAID effects (5 papers) and Atrial Fibrillation Management and Outcomes (3 papers). Michael J. Orwat collaborates with scholars based in United States and Germany. Michael J. Orwat's co-authors include Donald Pinto, Ruth R. Wexler, Robert M. Knabb, Patrick Y. S. Lam, Joseph M. Luettgen, Pancras C. Wong, Karen A. Rossi, Richard Alexander, Angela Smallwood and Kan He and has published in prestigious journals such as Journal of Medicinal Chemistry, Tetrahedron Letters and Chemical Research in Toxicology.

In The Last Decade

Michael J. Orwat

16 papers receiving 749 citations

Peers

Michael J. Orwat
Baomin Xin United States
Takayasu Nagahara Japan
Karen A. Rossi United States
Thomas Antonsson Sweden
Josef Pernerstorfer Germany
Yan Xia China
Valeria Chu United States
John M. Fevig United States
Satoshi Komoriya Japan
Jan-Erik Nyström Sweden
Baomin Xin United States
Michael J. Orwat
Citations per year, relative to Michael J. Orwat Michael J. Orwat (= 1×) peers Baomin Xin

Countries citing papers authored by Michael J. Orwat

Since Specialization
Citations

This map shows the geographic impact of Michael J. Orwat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. Orwat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. Orwat more than expected).

Fields of papers citing papers by Michael J. Orwat

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael J. Orwat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. Orwat. The network helps show where Michael J. Orwat may publish in the future.

Co-authorship network of co-authors of Michael J. Orwat

This figure shows the co-authorship network connecting the top 25 collaborators of Michael J. Orwat. A scholar is included among the top collaborators of Michael J. Orwat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael J. Orwat. Michael J. Orwat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Corte, James R., Tianan Fang, Donald Pinto, et al.. (2016). Orally bioavailable pyridine and pyrimidine-based Factor XIa inhibitors: Discovery of the methyl N-phenyl carbamate P2 prime group. Bioorganic & Medicinal Chemistry. 24(10). 2257–2272. 15 indexed citations
2.
Orwat, Michael J., Jennifer X. Qiao, Kan He, et al.. (2014). Orally bioavailable factor Xa inhibitors containing alpha-substituted gem-dimethyl P4 moieties. Bioorganic & Medicinal Chemistry Letters. 24(15). 3341–3345. 7 indexed citations
3.
Varnes, Jeffrey, Dean A. Wacker, Donald Pinto, et al.. (2007). Structure–activity relationship and pharmacokinetic profile of 5-ketopyrazole factor Xa inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(2). 749–754. 29 indexed citations
4.
5.
Pinto, Donald, Robert A. Galemmo, Mimi L. Quan, et al.. (2006). Discovery of potent, efficacious, and orally bioavailable inhibitors of blood coagulation factor Xa with neutral P1 moieties. Bioorganic & Medicinal Chemistry Letters. 16(21). 5584–5589. 23 indexed citations
6.
Lam, Patrick Y. S., Charles G. Clark, Renhua Li, et al.. (2003). Structure-Based Design of Novel Guanidine/Benzamidine Mimics:  Potent and Orally Bioavailable Factor Xa Inhibitors as Novel Anticoagulants. Journal of Medicinal Chemistry. 46(21). 4405–4418. 70 indexed citations
7.
Fevig, John M., Donald Pinto, Qi Han, et al.. (2001). Synthesis and SAR of benzamidine factor Xa inhibitors containing a vicinally-substituted heterocyclic core. Bioorganic & Medicinal Chemistry Letters. 11(5). 641–645. 31 indexed citations
8.
9.
10.
Pinto, Donald, Douglas G. Batt, William J. Pitts, et al.. (1999). Terphenyl cyclooxygenase-2 (COX-2) inhibitors: Optimization of the central ring and o-biphenyl analogs. Bioorganic & Medicinal Chemistry Letters. 9(7). 919–924. 17 indexed citations
11.
Pitts, William J., James W. Jetter, Donald Pinto, et al.. (1998). Structure-activity relationships (SAR) of some tetracyclic heterocycles related to the immunosuppressive agent brequinar sodium. Bioorganic & Medicinal Chemistry Letters. 8(3). 307–312. 15 indexed citations
12.
Rider, Nicholas L., Donald Pinto, Maryanne Covington, et al.. (1996). Comparative Effects of Selective Cyclooxygenase 1 and Cyclooxygenase 2 Inhibitors on Myeloperoxidase and 3α-Hydroxysteroid Dehydrogenase. Journal of enzyme inhibition. 10(2). 73–79. 2 indexed citations
13.
Pinto, Donald, Robert A. Copeland, Maryanne Covington, et al.. (1996). Chemistry and pharmacokinetics of diarylthiophenes and terphenyls as selective COX-2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 6(24). 2907–2912. 30 indexed citations
14.
Wright, Stephen W., Joseph J. Petraitis, Douglas G. Batt, et al.. (1995). Metabolism resistant isothiazolone inhibitors of cartilage breakdown. Bioorganic & Medicinal Chemistry. 3(3). 227–234. 10 indexed citations
15.
Batt, Douglas G., Robert A. Copeland, Randine L. Dowling, et al.. (1995). Immunosuppressive structure-activity relationships of Brequinar and related cinchoninic acid derivatives. Bioorganic & Medicinal Chemistry Letters. 5(14). 1549–1554. 23 indexed citations
16.
Kende, Andrew S., Kuniaki Kawamura, & Michael J. Orwat. (1989). Enantioselective synthesis of the α,α-dimethyl-β-hydroxy. Tetrahedron Letters. 30(43). 5821–5824. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Baomin Xin Breakdown of academic impact, for papers by Takayasu Nagahara Breakdown of academic impact, for papers by Karen A. Rossi Breakdown of academic impact, for papers by Thomas Antonsson Breakdown of academic impact, for papers by Josef Pernerstorfer Breakdown of academic impact, for papers by Yan Xia Breakdown of academic impact, for papers by Valeria Chu Breakdown of academic impact, for papers by John M. Fevig Breakdown of academic impact, for papers by Satoshi Komoriya Breakdown of academic impact, for papers by Jan-Erik Nyström
Rankless by CCL
2026